The prominent nuclear staining seen in T47D breast cancer cells with the anti-MUC1ARF mAb 2G10 was abrogated by addition of competing MUC1-ARF peptide (compare Fig 5, panels C and D), showing antibody specificity. This evidence concerns the gene MUC1 and breast carcinoma.